Benign Prostatic Hyperplasia Procedures in Patients with Prostate Cancer:: What Do We Know?

Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) frequently coexist, posing unique challenges for the clinician. This article explores how various surgical and minimally invasive therapies for BPH can be utilized in patients with PCa, including those managing with active surveillance or pursuing radiation treatment. The discussion herein highlights the efficacy, complications, and oncological implications of these treatments. Ultimately, treatment selection requires shared decision-making and a multidisciplinary approach to achieving symptom relief while maintaining cancer control. Future research will be critical to refine best practices and assess long-term outcomes in these clinical situations.